Key result
Silencing circHIPK2 in macrophages reduces post-MI inflammation and fibrosis, protecting cardiac function in preclinical models.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“We have identified circHIPK2 as an important regulator of macrophage polarization after a heart attack. As a molecular switch, circHIPK2 promotes the formation of so-called stress granules in the macrophages.”
“The targeted elimination of circHIPK2 in macrophages reduced inflammatory reactions, slowed down scarring of the heart muscle and significantly improved cardiac performance. This unique platform enabled us to translate the molecular findings into a clinically significant context - and to show that silencing circHIPK2 promotes cardiac healing and reduces inflammatory damage.”
“In this issue of the European Heart Journal, the study by Mira Jung and co-workers adds a new and intriguing player to this scene: macrophage-specific circular RNA circHIPK2. By interacting with G3BP1, circHIPK2 facilitates stress granule formation and amplifies downstream inflammatory cascades. Inhibiting circHIPK2 disrupts this axis, leading to reduced stress granule assembly, dampened inflammatory signalling, and lower production of proinflammatory mediators.”
Preclinical study reveals that silencing macrophage circHIPK2 attenuates inflammation and fibrosis after myocardial infarction in mice, suggesting a novel RNA target for heart failure therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2026) conducted an editorial in Myocardial infarction. Macrophage-specific circHIPK2 silencing was evaluated. Silencing of circHIPK2 in macrophages reduced inflammation, fibrosis, and protected cardiac function after myocardial infarction in preclinical models.
Synapse has enriched 10 related papers. Consider them for comparative context: